T2EVOLVE

  • Advanced Therapies Europe
  • Partner

The strategic objective of T2EVOLVE is to accelerate the process of developing CAR T-cell therapy in the European Union (EU), to grant EU patients access to the most ground-breaking and best available medical care, while providing guidance on the implementation of this novel treatment into the EU healthcare system in a sustainable way, and to help alleviate the financial burden of health care on the economy and society. Moreover, patient involvement will ensure that the perspectives of cancer patients are at the center, in the research setting as well as along the cancer care continuum. 

Address

N/A
N/A
Germany

Website

https://t2evolve.com/

Contact Exhibitor


Loading
View all Exhibitors